Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells

Immunobiology

Volumn 220, Issue 2, 2015, Pages 227-235

  Schey, Regina ^a   Danzer, Claudia ^a   Mattner, Jochen ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Inflammatory bowel disease; Intestinal microbiota; Mucosal tolerance; Myeloid cells; Surface molecules

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD103 ANTIGEN; CD14 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 23; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; MEMBRANE ANTIGEN;

ADOPTIVE TRANSFER; BACTEROIDES; BIFIDOBACTERIUM; BONE MARROW CELL; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE SEVERITY; EFFECTOR CELL; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LAMINA PROPRIA; MACROPHAGE; MONOCYTE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; ANIMAL; BACTERIUM; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MICROFLORA; PHENOTYPE;

ANIMALS; ANTIGENS, SURFACE; BACTERIA; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICROBIOTA; MYELOID CELLS; PHENOTYPE;

EID: 84926287212     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.11.014     Document Type: Review

References (133)

1. Andrew D.P., Rott L.S., Kilshaw P.J., Butcher E.C. Distribution of alpha 4 beta 7 and alpha E beta 7 integrins on thymocytes, intestinal epithelial lymphocytes and peripheral lymphocytes. Eur. J. Immunol. 1996, 26:897-905.
2. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 2005, 202:1051-1061.
3. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001, 2:1144-1150.
4. Bain C.C., Mowat A.M. Macrophages in intestinal homeostasis and inflammation. Immunol. Rev. 2014, 260:102-117.
5. Bamias G., Martin C., Marini M., Hoang S., Mishina M., Ross W.G., Sachedina M.A., Friel C.M., Mize J., Bickston S.J., Pizarro T.T., Wei P., Cominelli F. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 2003, 171:4868-4874.
6. Bamias G., Mishina M., Nyce M., Ross W.G., Kollias G., Rivera-Nieves J., Pizarro T.T., Cominelli F. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8441-8446.
7. Barrett R., Zhang X., Koon H.W., Vu M., Chang J.Y., Yeager N., Nguyen M.A., Michelsen K.S., Berel D., Pothoulakis C., Targan S.R., Shih D.Q. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am. J. Pathol. 2012, 180:636-649.
8. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
9. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995, 96:2339-2347.
10. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12:20-26.
11. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
12. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991, 174:1549-1555.
13. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto D., Greter M., Liu K., Jakubzick C., Ingersoll M.A., Leboeuf M., Stanley E.R., Nussenzweig M., Lira S.A., Randolph G.J., Merad M. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
14. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000, 164:4991-4995.
15. Brand S., Sakaguchi T., Gu X., Colgan S.P., Reinecker H.C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 2002, 122:166-177.
16. Breese E.J., Michie C.A., Nicholls S.W., Murch S.H., Williams C.B., Domizio P., Walker-Smith J.A., MacDonald T.T. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994, 106:1455-1466.
17. Buffie C.G., Bucci V., Stein R.R., McKenney P.T., Ling L., Gobourne A., No D., Liu H., Kinnebrew M., Viale A., Littmann E., van den Brink M.R., Jenq R.R., Taur Y., Sander C., Cross J., Toussaint N.C., Xavier J.B., Pamer E.G. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2014.
18. Bullock N.R., Booth J.C., Gibson G.R. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr. Issues Intest. Microbiol. 2004, 5:59-64.
19. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., Doherty J.M., Mills J.C., Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
20. Cepek K.L., Parker C.M., Madara J.L., Brenner M.B. Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells. J. Immunol. 1993, 150:3459-3470.
21. Cepek K.L., Shaw S.K., Parker C.M., Russell G.J., Morrow J.S., Rimm D.L., Brenner M.B. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994, 372:190-193.
22. Cerf-Bensussan N., Jarry A., Brousse N., Lisowska-Grospierre B., Guy-Grand D., Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol. 1987, 17:1279-1285.
23. Cerovic V., Bain C.C., Mowat A.M., Milling S.W. Intestinal macrophages and dendritic cells: what's the difference?. Trends Immunol. 2014, 35:270-277.
24. Cohen-Poradosu R., McLoughlin R.M., Lee J.C., Kasper D.L. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. J. Infect. Dis. 2011, 204:363-371.
25. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
26. Coombes J.L., Powrie F. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 2008, 8:435-446.
27. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 2009, 10:66-74.
28. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
29. Feagan B.G., Sandborn W.J., Baker J.P., Cominelli F., Sutherland L.R., Elson C.O., Salzberg B.A., Archambault A., Bernstein C.N., Lichtenstein G.R., Heath P.K., Cameron S., Hanauer S.B. A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. Aliment. Pharmacol. Ther. 2005, 21:373-384.
30. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13780-13785.
31. Freudenberg M.A., Tchaptchet S., Keck S., Fejer G., Huber M., Schutze N., Beutler B., Galanos C. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008, 213:193-203.
32. Frolova L., Drastich P., Rossmann P., Klimesova K., Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J. Histochem. Cytochem. 2008, 56:267-274.
33. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
34. Garrett W.S., Gordon J.I., Glimcher L.H. Homeostasis and inflammation in the intestine. Cell 2010, 140:859-870.
35. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111:927-930.
36. Hadis U., Wahl B., Schulz O., Hardtke-Wolenski M., Schippers A., Wagner N., Muller W., Sparwasser T., Forster R., Pabst O. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011, 34:237-246.
37. Hadley G.A., Bartlett S.T., Via C.S., Rostapshova E.A., Moainie S. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL. J. Immunol. 1997, 159:3748-3756.
38. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
39. Hermiston M.L., Gordon J.I. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 1995, 129:489-506.
40. Hollander D. Inflammatory bowel diseases and brain-gut axis. J. Physiol. Pharmacol. 2003, 54(Suppl 4):183-190.
41. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168:4531-4537.
42. Hynes R.O. Integrins: a family of cell surface receptors. Cell 1987, 48:549-554.
43. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
44. Itano A.A., Jenkins M.K. Antigen presentation to naive CD4T cells in the lymph node. Nat. Immunol. 2003, 4:733-739.
45. Iwasaki A., Kelsall B.L. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J. Immunol. 2001, 166:4884-4890.
46. Iwasaki A. Mucosal dendritic cells. Annu. Rev. Immunol. 2007, 25:381-418.
47. Jang M.H., Sougawa N., Tanaka T., Hirata T., Hiroi T., Tohya K., Guo Z., Umemoto E., Ebisuno Y., Yang B.G., Seoh J.Y., Lipp M., Kiyono H., Miyasaka M. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 2006, 176:803-810.
48. Jerala R. Structural biology of the LPS recognition. Int. J. Med. Microbiol. 2007, 297:353-363.
49. Jersmann H.P. Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol. Cell Biol. 2005, 83:462-467.
50. Jiang Z., Zamanian-Daryoush M., Nie H., Silva A.M., Williams B.R., Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 2003, 278:16713-16719.
51. Jung Y.S., Park J.J., Kim S.W., Hong S.P., Kim T.I., Kim W.H., Cheon J.H. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Dig. Liver Dis. 2012, 44:897-903.
52. Kakuta Y., Kinouchi Y., Negoro K., Takahashi S., Shimosegawa T. Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut 2006, 55:1527-1528.
53. Kaser A., Ludwiczek O., Holzmann S., Moschen A.R., Weiss G., Enrich B., Graziadei I., Dunzendorfer S., Wiedermann C.J., Murzl E., Grasl E., Jasarevic Z., Romani N., Offner F.A., Tilg H. Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 2004, 24:74-85.
54. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
55. Kelly K., Manos E., Jensen G., Nadauld L., Jones D.A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000, 60:1021-1027.
56. Kilshaw P.J., Murant S.J. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur. J. Immunol. 1990, 20:2201-2207.
57. Kilshaw P.J. Expression of the mucosal T cell integrin alpha M290 beta 7 by a major subpopulation of dendritic cells in mice. Eur. J. Immunol. 1993, 23:3365-3368.
58. Kinnebrew M.A., Buffie C.G., Diehl G.E., Zenewicz L.A., Leiner I., Hohl T.M., Flavell R.A., Littman D.R., Pamer E.G. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
59. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., Eitner K., Marx M., Duerig N., Epplen J.T. A polymorphism in the CD14 gene is associated with Crohn disease. Scand. J. Gastroenterol. 2002, 37:189-191.
60. Knapp S., Gibot S., de Vos A., Versteeg H.H., Colonna M., van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J. Immunol. 2004, 173:7131-7134.
61. Kostadinova F.I., Baba T., Ishida Y., Kondo T., Popivanova B.K., Mukaida N. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice. J. Leukoc. Biol. 2010, 88:133-143.
62. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
63. Laffont S., Siddiqui K.R., Powrie F. Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. Eur. J. Immunol. 2010, 40:1877-1883.
64. Lee J.D., Kato K., Tobias P.S., Kirkland T.N., Ulevitch R.J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 1992, 175:1697-1705.
65. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., Dalod M., Littman D.R., Vivier E., Tomasello E. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009, 10:75-82.
66. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
67. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211.
68. Medina-Contreras O., Geem D., Laur O., Williams I.R., Lira S.A., Nusrat A., Parkos C.A., Denning T.L. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 2011, 121:4787-4795.
69. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J.S., Perry J.W., Chen S.F., Zhou J.X., Cho Y.H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H.S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P.A., Ruben S.M., Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
70. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
71. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009, 10:1178-1184.
72. Muzio M., Bosisio D., Polentarutti N., D'Amico G., Stoppacciaro A., Mancinelli R., van't Veer C., Penton-Rol G., Ruco L.P., Allavena P., Mantovani A. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 2000, 164:5998-6004.
73. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
74. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., Sosnovtseva S., Carrell J.A., Feng P., Giri J.G., Hilbert D.M. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001, 97:198-204.
75. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
76. Nicholls S., Stephens S., Braegger C.P., Walker-Smith J.A., MacDonald T.T. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J. Clin. Pathol. 1993, 46:757-760.
77. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258.
78. Niess J.H., Adler G. Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. J. Immunol. 2010, 184:2026-2037.
79. Obana N., Takahashi S., Kinouchi Y., Negoro K., Takagi S., Hiwatashi N., Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand. J. Gastroenterol. 2002, 37:699-704.
80. Oku R., Oda S., Nakada T.A., Sadahiro T., Nakamura M., Hirayama Y., Abe R., Tateishi Y., Ito M., Iseki T., Hirasawa H. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine 2013, 61:112-117.
81. Park J.J., Cheon J.H., Kim B.Y., Kim D.H., Kim E.S., Kim T.I., Lee K.R., Kim W.H. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig. Dis. Sci. 2009, 54:1525-1531.
82. Pearson C., Uhlig H.H., Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol. 2012, 33:289-296.
83. Picornell Y., Mei L., Taylor K., Yang H., Targan S.R., Rotter J.I. TNFSF15 is an ethnic-specific IBD gene. Inflamm. Bowel Dis. 2007, 13:1333-1338.
84. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 2002, 347:417-429.
85. Raetz C.R. Biochemistry of endotoxins. Annu. Rev. Biochem 1990, 59:129-170.
86. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
87. Raport C.J., Schweickart V.L., Eddy R.L., Shows T.B., Gray P.W. The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues. Gene 1995, 163:295-299.
88. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., Mazmanian S.K. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
89. Salim S.Y., Silva M.A., Keita A.V., Larsson M., Andersson P., Magnusson K.E., Perdue M.H., Soderholm J.D. CD83+CCR7-dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease. Am. J. Pathol. 2009, 174:82-90.
90. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009, 10:83-91.
91. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.J., Thiam K., Cerf-Bensussan N., Mandelboim O., Eberl G., Di Santo J.P. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
92. Schenk M., Bouchon A., Birrer S., Colonna M., Mueller C. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J. Immunol. 2005, 174:517-524.
93. Schenk M., Bouchon A., Seibold F., Mueller C. TREM-1 - expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J. Clin. Invest. 2007, 117:3097-3106.
94. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999, 189:1747-1756.
95. Schon M.P., Arya A., Murphy E.A., Adams C.M., Strauch U.G., Agace W.W., Marsal J., Donohue J.P., Her H., Beier D.R., Olson S., Lefrancois L., Brenner M.B., Grusby M.J., Parker C.M. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J. Immunol. 1999, 162:6641-6649.
96. Schreiber S., Rutgeerts P., Fedorak R.N., Khaliq-Kareemi M., Kamm M.A., Boivin M., Bernstein C.N., Staun M., Thomsen O.O., Innes A., Group, C.D.P.C.s.D.S. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology 2005, 129:807-818.
97. Schreiber S., Khaliq-Kareemi M., Lawrance I.C., Thomsen O.O., Hanauer S.B., McColm J., Bloomfield R., Sandborn W.J., Investigators P.S. Maintenance therapy with certolizumab pegol for Crohn's disease. N. Engl. J. Med. 2007, 357:239-250.
98. Schulz O., Jaensson E., Persson E.K., Liu X., Worbs T., Agace W.W., Pabst O. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med. 2009, 206:3101-3114.
99. Scott C.L., Aumeunier A.M., Mowat A.M. Intestinal CD103+ dendritic cells: master regulators of tolerance?. Trends Immunol. 2011, 32:412-419.
100. Screaton G.R., Xu X.N., Olsen A.L., Cowper A.E., Tan R., McMichael A.J., Bell J.I. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4615-4619.
101. Seldenrijk C.A., Drexhage H.A., Meuwissen S.G., Pals S.T., Meijer C.J. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut 1989, 30:484-491.
102. Shanahan F. The host-microbe interface within the gut. Best Pract. Res. Clin. Gastroenterol. 2002, 16:915-931.
103. Shih D.Q., Kwan L.Y., Chavez V., Cohavy O., Gonsky R., Chang E.Y., Chang C., Elson C.O., Targan S.R. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 2009, 39:3239-3250.
104. Shu H.B., Hu W.H., Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 1999, 65:680-683.
105. Siddiqui K.R., Laffont S., Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 2010, 32:557-567.
106. Siegel R.M., Chan F.K., Chun H.J., Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 2000, 1:469-474.
107. Smith P.D., Ochsenbauer-Jambor C., Smythies L.E. Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 2005, 206:149-159.
108. Spencer R.C. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 1998, 41(Suppl. C):21-27.
109. Spencer S.D., Di Marco F., Hooley J., Pitts-Meek S., Bauer M., Ryan A.M., Sordat B., Gibbs V.C., Aguet M. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 1998, 187:571-578.
110. Stack W.A., Mann S.D., Roy A.J., Heath P., Sopwith M., Freeman J., Holmes G., Long R., Forbes A., Kamm M.A. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 1997, 349:521-524.
111. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 1999, 65:4799-4807.
112. Surana N.K., Kasper D.L. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol. Rev. 2012, 245:13-26.
113. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
114. Takedatsu H., Michelsen K.S., Wei B., Landers C.J., Thomas L.S., Dhall D., Braun J., Targan S.R. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008, 135:552-567.
115. Tang A., Amagai M., Granger L.G., Stanley J.R., Udey M.C. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993, 361:82-85.
116. Te Velde A.A., van Kooyk Y., Braat H., Hommes D.W., Dellemijn T.A., Slors J.F., van Deventer S.J., Vyth-Dreese F.A. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 2003, 33:143-151.
117. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., Gordon J.I. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
118. Tzivras M., Koussoulas V., Giamarellos-Bourboulis E.J., Tzivras D., Tsaganos T., Koutoukas P., Giamarellou H., Archimandritis A. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J. Gastroenterol. 2006, 12:3416-3419.
119. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., Speelman P., Dijkgraaf M.G., Keller J.J. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368:407-415.
120. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., Fehling H.J., Hardt W.D., Shakhar G., Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
121. Varol C., Zigmond E., Jung S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat. Rev. Immunol. 2010, 10:415-426.
122. Wang Q., McLoughlin R.M., Cobb B.A., Charrel-Dennis M., Zaleski K.J., Golenbock D., Tzianabos A.O., Kasper D.L. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 2006, 203:2853-2863.
123. Weber B., Schuster S., Zysset D., Rihs S., Dickgreber N., Schurch C., Riether C., Siegrist M., Schneider C., Pawelski H., Gurzeler U., Ziltener P., Genitsch V., Tacchini-Cottier F., Ochsenbein A., Hofstetter W., Kopf M., Kaufmann T., Oxenius A., Reith W., Saurer L., Mueller C. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog 2014, 10:e1003900.
124. Wheelock M.J., Jensen P.J. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J. Cell Biol. 1992, 117:415-425.
125. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Jarnerot G., Engstrand L., Tysk C., Jansson J.K. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 2009, 15:653-660.
126. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
127. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., Cardon L., Takazoe M., Tanaka T., Ichimori T., Saito S., Sekine A., Iida A., Takahashi A., Tsunoda T., Lathrop M., Nakamura Y. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 2005, 14:3499-3506.
128. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., Yost E.A., Gruber A.D., May M.J., Greten F.R., Eckmann L., Karin M., Artis D. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007, 446:552-556.
129. Zhang M., Liu B., Zhang Y., Wei H., Lei Y., Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J. Clin. Microbiol. 2007, 45:496-500.
130. Zhao C., Wang I., Lehrer R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996, 396:319-322.
131. Zhou J., Chai F., Lu G., Hang G., Chen C., Chen X., Shi J. TREM-1 inhibition attenuates inflammation and tumor within the colon. Int. Immunopharmacol. 2013, 17:155-161.
132. Zigmond E., Varol C., Farache J., Elmaliah E., Satpathy A.T., Friedlander G., Mack M., Shpigel N., Boneca I.G., Murphy K.M., Shakhar G., Halpern Z., Jung S. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090.
133. Zigmond E., Bernshtein B., Friedlander G., Walker C.R., Yona S., Kim K.W., Brenner O., Krauthgamer R., Varol C., Muller W., Jung S. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 2014, 40:720-733.